{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:41:08Z","timestamp":1790523668157,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T00:00:00Z","timestamp":1248912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T00:00:00Z","timestamp":1248912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/gt.2009.93","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T10:23:56Z","timestamp":1248949436000},"page":"1300-1313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen"],"prefix":"10.1038","volume":"16","author":[{"given":"S","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Hel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,30]]},"reference":[{"key":"BFgt200993_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-065X.2007.00575.x","volume":"220","author":"AK Palucka","year":"2007","unstructured":"Palucka AK, Ueno H, Fay JW, Banchereau J . Taming cancer by inducing immunity via dendritic cells. Immunol Rev 2007; 220: 129\u2013150.","journal-title":"Immunol Rev"},{"key":"BFgt200993_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1081\/CNV-120025091","volume":"21","author":"D Ridgway","year":"2003","unstructured":"Ridgway D . The first 1000 dendritic cell vaccinees. Cancer Invest 2003; 21: 873\u2013886.","journal-title":"Cancer Invest"},{"key":"BFgt200993_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nm1039","volume":"10","author":"CG Figdor","year":"2004","unstructured":"Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ . Dendritic cell immunotherapy: mapping the way. Nat Med 2004; 10: 475\u2013480.","journal-title":"Nat Med"},{"key":"BFgt200993_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0065-230X(07)99006-5","volume":"99","author":"A Vulink","year":"2008","unstructured":"Vulink A, Radford KJ, Melief C, Hart DN . Dendritic cells in cancer immunotherapy. Adv Cancer Res 2008; 99: 363\u2013407.","journal-title":"Adv Cancer Res"},{"key":"BFgt200993_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.it.2004.09.016","volume":"25","author":"JL Schultze","year":"2004","unstructured":"Schultze JL, Grabbe S, Bergwelt-Baildon MS . DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Trends Immunol 2004; 25: 659\u2013664.","journal-title":"Trends Immunol"},{"key":"BFgt200993_CR6","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1182\/blood-2003-07-2379","volume":"103","author":"CM Coughlin","year":"2004","unstructured":"Coughlin CM, Vance BA, Grupp SA, Vonderheide RH . RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. Blood 2004; 103: 2046\u20132054.","journal-title":"Blood"},{"key":"BFgt200993_CR7","first-page":"8513","volume":"61","author":"JD Geiger","year":"2001","unstructured":"Geiger JD, Hutchinson RJ, Hohenkirk LF, McKenna EA, Yanik GA, Levine JE et al. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res 2001; 61: 8513\u20138519.","journal-title":"Cancer Res"},{"key":"BFgt200993_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/mpo.1303","volume":"38","author":"R Dagher","year":"2002","unstructured":"Dagher R, Long LM, Read EJ, Leitman SF, Carter CS, Tsokos M et al. Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study. Med Pediatr Oncol 2002; 38: 158\u2013164.","journal-title":"Med Pediatr Oncol"},{"key":"BFgt200993_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpedsurg.2006.09.008","volume":"42","author":"J Shilyansky","year":"2007","unstructured":"Shilyansky J, Jacobs P, Doffek K, Sugg SL . Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor. J Pediatr Surg 2007; 42: 54\u201361.","journal-title":"J Pediatr Surg"},{"key":"BFgt200993_CR10","first-page":"56","volume":"59","author":"MA Morse","year":"1999","unstructured":"Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK . Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res 1999; 59: 56\u201358.","journal-title":"Cancer Res"},{"key":"BFgt200993_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nbt1154","volume":"23","author":"IJ de Vries","year":"2005","unstructured":"de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005; 23: 1407\u20131413.","journal-title":"Nat Biotechnol"},{"key":"BFgt200993_CR12","first-page":"139","volume-title":"Cancer and Gene Therapy, 1st edn","author":"Z Hel","year":"2007","unstructured":"Hel Z . Cancer immunotherapy with activated B cells. In: Hemorhat PL (ed). Cancer and Gene Therapy, 1st edn. Transworld Research Network, 2007, pp 139\u2013153."},{"key":"BFgt200993_CR13","first-page":"2836","volume":"63","author":"R Lapointe","year":"2003","unstructured":"Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P . CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 2003; 63: 2836\u20132843.","journal-title":"Cancer Res"},{"key":"BFgt200993_CR14","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI119822","volume":"100","author":"JL Schultze","year":"1997","unstructured":"Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J et al. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 1997; 100: 2757\u20132765.","journal-title":"J Clin Invest"},{"key":"BFgt200993_CR15","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1182\/blood.V99.9.3319","volume":"99","author":"MS Bergwelt-Baildon","year":"2002","unstructured":"Bergwelt-Baildon MS, Vonderheide RH, Maecker B, Hirano N, Anderson KS, Butler MO et al. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 2002; 99: 3319\u20133325.","journal-title":"Blood"},{"key":"BFgt200993_CR16","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.4049\/jimmunol.169.4.2164","volume":"169","author":"E Kondo","year":"2002","unstructured":"Kondo E, Topp MS, Kiem HP, Obata Y, Morishima Y, Kuzushima K et al. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J Immunol 2002; 169: 2164\u20132171.","journal-title":"J Immunol"},{"key":"BFgt200993_CR17","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1073\/pnas.0400138101","volume":"101","author":"M Gerloni","year":"2004","unstructured":"Gerloni M, Rizzi M, Castiglioni P, Zanetti M . T cell immunity using transgenic B lymphocytes. Proc Natl Acad Sci USA 2004; 101: 3892\u20133897.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200993_CR18","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.4049\/jimmunol.172.3.1501","volume":"172","author":"A Heit","year":"2004","unstructured":"Heit A, Huster KM, Schmitz F, Schiemann M, Busch DH, Wagner H . CpG-DNA aided cross-priming by cross-presenting B cells. J Immunol 2004; 172: 1501\u20131507.","journal-title":"J Immunol"},{"key":"BFgt200993_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/blood-2003-09-3211","volume":"104","author":"C Palena","year":"2004","unstructured":"Palena C, Zhu M, Schlom J, Tsang KY . Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cells. Blood 2004; 104: 192\u2013199.","journal-title":"Blood"},{"key":"BFgt200993_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.0105-2896.2004.00152.x","volume":"199","author":"M Zanetti","year":"2004","unstructured":"Zanetti M, Castiglioni P, Rizzi M, Wheeler M, Gerloni M . B lymphocytes as antigen-presenting cell-based genetic vaccines. Immunol Rev 2004; 199: 264\u2013278.","journal-title":"Immunol Rev"},{"key":"BFgt200993_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.humimm.2006.12.004","volume":"68","author":"C Zentz","year":"2007","unstructured":"Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P et al. Activated B cells mediate efficient expansion of rare antigen-specific T cells. Hum Immunol 2007; 68: 75\u201385.","journal-title":"Hum Immunol"},{"key":"BFgt200993_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2567.2007.02749.x","volume":"124","author":"T Ahmadi","year":"2008","unstructured":"Ahmadi T, Flies A, Efebera Y, Sherr DH . CD40 ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides. Immunology 2008; 124: 129\u2013140.","journal-title":"Immunology"},{"key":"BFgt200993_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.0300-9475.2004.01517.x","volume":"60","author":"DS Ritchie","year":"2004","unstructured":"Ritchie DS, Yang J, Hermans IF, Ronchese F . B-lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells. Scand J Immunol 2004; 60: 543\u2013551.","journal-title":"Scand J Immunol"},{"key":"BFgt200993_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2567.2008.02833.x","volume":"125","author":"J Lee","year":"2008","unstructured":"Lee J, Dollins CM, Boczkowski D, Sullenger BA, Nair S . Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses. Immunology 2008; 125: 229\u2013240.","journal-title":"Immunology"},{"key":"BFgt200993_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/CJI.0b013e31802bd9c8","volume":"30","author":"V Watt","year":"2007","unstructured":"Watt V, Ronchese F, Ritchie D . Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism. J Immunother 2007; 30: 323\u2013332.","journal-title":"J Immunother"},{"key":"BFgt200993_CR26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4049\/jimmunol.172.2.954","volume":"172","author":"M Wagner","year":"2004","unstructured":"Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B et al. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol 2004; 172: 954\u2013963.","journal-title":"J Immunol"},{"key":"BFgt200993_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.169.2.787","volume":"169","author":"H Shirota","year":"2002","unstructured":"Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T et al. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J Immunol 2002; 169: 787\u2013794.","journal-title":"J Immunol"},{"key":"BFgt200993_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.189.1.1","volume":"189","author":"JL Schultze","year":"1999","unstructured":"Schultze JL, Michalak S, Lowne J, Wong A, Gilleece MH, Gribben JG et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med 1999; 189: 1\u201312.","journal-title":"J Exp Med"},{"key":"BFgt200993_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ymthe.2004.07.017","volume":"10","author":"M Dullaers","year":"2004","unstructured":"Dullaers M, Breckpot K, Van Meirvenne S, Bonehill A, Tuyaerts S, Michiels A et al. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols. Mol Ther 2004; 10: 768\u2013779.","journal-title":"Mol Ther"},{"key":"BFgt200993_CR30","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.4049\/jimmunol.169.12.6842","volume":"169","author":"J Valenzuela","year":"2002","unstructured":"Valenzuela J, Schmidt C, Mescher M . The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol 2002; 169: 6842\u20136849.","journal-title":"J Immunol"},{"key":"BFgt200993_CR31","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.4049\/jimmunol.172.5.2818","volume":"172","author":"J Chang","year":"2004","unstructured":"Chang J, Cho JH, Lee SW, Choi SY, Ha SJ, Sung YC . IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J Immunol 2004; 172: 2818\u20132826.","journal-title":"J Immunol"},{"key":"BFgt200993_CR32","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.4049\/jimmunol.181.12.8576","volume":"181","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM . IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 2008; 181: 8576\u20138584.","journal-title":"J Immunol"},{"key":"BFgt200993_CR33","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.4049\/jimmunol.174.6.3808","volume":"174","author":"Y He","year":"2005","unstructured":"He Y, Zhang J, Mi Z, Robbins P, Falo Jr LD . Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J Immunol 2005; 174: 3808\u20133817.","journal-title":"J Immunol"},{"key":"BFgt200993_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1155\/2001\/91831","volume":"8","author":"LC Zhao","year":"2001","unstructured":"Zhao LC, Edgar JB, Dailey MO . Characterization of the rapid proteolytic shedding of murine L-selectin. Dev Immunol 2001; 8: 267\u2013277.","journal-title":"Dev Immunol"},{"key":"BFgt200993_CR35","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1084\/jem.20030485","volume":"198","author":"E Galkina","year":"2003","unstructured":"Galkina E, Tanousis K, Preece G, Tolaini M, Kioussis D, Florey O et al. L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med 2003; 198: 1323\u20131335.","journal-title":"J Exp Med"},{"key":"BFgt200993_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W . Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295\u2013307.","journal-title":"Nat Rev Immunol"},{"key":"BFgt200993_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri2216","volume":"8","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G . Immunological aspects of cancer chemotherapy. Nat Rev Immunol 2008; 8: 59\u201373.","journal-title":"Nat Rev Immunol"},{"key":"BFgt200993_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.gt.3302947","volume":"14","author":"K Breckpot","year":"2007","unstructured":"Breckpot K, Aerts JL, Thielemans K . Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Gene Therapy 2007; 14: 847\u2013862.","journal-title":"Gene Therapy"},{"key":"BFgt200993_CR39","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1172\/JCI30605","volume":"117","author":"V Russo","year":"2007","unstructured":"Russo V, Cipponi A, Raccosta L, Rainelli C, Fontana R, Maggioni D et al. Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity. J Clin Invest 2007; 117: 3087\u20133096.","journal-title":"J Clin Invest"},{"key":"BFgt200993_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0065-2660(05)54009-4","volume":"54","author":"PB Hackett","year":"2005","unstructured":"Hackett PB, Ekker SC, Largaespada DA, McIvor RS . Sleeping beauty transposon-mediated gene therapy for prolonged expression. Adv Genet 2005; 54: 189\u2013232.","journal-title":"Adv Genet"},{"key":"BFgt200993_CR41","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.4049\/jimmunol.161.8.4023","volume":"161","author":"AA Amoscato","year":"1998","unstructured":"Amoscato AA, Prenovitz DA, Lotze MT . Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. J Immunol 1998; 161: 4023\u20134032.","journal-title":"J Immunol"},{"key":"BFgt200993_CR42","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/eji.200324355","volume":"34","author":"D Zehn","year":"2004","unstructured":"Zehn D, Cohen CJ, Reiter Y, Walden P . Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells. Eur J Immunol 2004; 34: 1551\u20131560.","journal-title":"Eur J Immunol"},{"key":"BFgt200993_CR43","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.0308345101","volume":"101","author":"L Shen","year":"2004","unstructured":"Shen L, Rock KL . Cellular protein is the source of cross-priming antigen in vivo. Proc Natl Acad Sci USA 2004; 101: 3035\u20133040.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200993_CR44","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.173.4.2241","volume":"173","author":"AT Stock","year":"2004","unstructured":"Stock AT, Mueller SN, van Lint AL, Heath WR, Carbone FR . Cutting edge: prolonged antigen presentation after herpes simplex virus-1 skin infection. J Immunol 2004; 173: 2241\u20132244.","journal-title":"J Immunol"},{"key":"BFgt200993_CR45","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.4049\/jimmunol.171.10.5165","volume":"171","author":"JM Curtsinger","year":"2003","unstructured":"Curtsinger JM, Johnson CM, Mescher MF . CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 2003; 171: 5165\u20135171.","journal-title":"J Immunol"},{"key":"BFgt200993_CR46","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1084\/jem.20060928","volume":"203","author":"M Prlic","year":"2006","unstructured":"Prlic M, Hernandez-Hoyos G, Bevan MJ . Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J Exp Med 2006; 203: 2135\u20132143.","journal-title":"J Exp Med"},{"key":"BFgt200993_CR47","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.4049\/jimmunol.173.11.6694","volume":"173","author":"MA Williams","year":"2004","unstructured":"Williams MA, Bevan MJ . Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J Immunol 2004; 173: 6694\u20136702.","journal-title":"J Immunol"},{"key":"BFgt200993_CR48","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.188.11.1977","volume":"188","author":"SR Bennett","year":"1998","unstructured":"Bennett SR, Carbone FR, Toy T, Miller JF, Heath WR . B cells directly tolerize CD8(+) T cells. J Exp Med 1998; 188: 1977\u20131983.","journal-title":"J Exp Med"},{"key":"BFgt200993_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nm0598-627","volume":"4","author":"Z Qin","year":"1998","unstructured":"Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T . B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 1998; 4: 627\u2013630.","journal-title":"Nat Med"},{"key":"BFgt200993_CR50","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1182\/blood-2006-10-053793","volume":"110","author":"P Reichardt","year":"2007","unstructured":"Reichardt P, Dornbach B, Rong S, Beissert S, Gueler F, Loser K et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007; 110: 1519\u20131529.","journal-title":"Blood"},{"key":"BFgt200993_CR51","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.164.2.688","volume":"164","author":"DE Evans","year":"2000","unstructured":"Evans DE, Munks MW, Purkerson JM, Parker DC . Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand\/CD40. J Immunol 2000; 164: 688\u2013697.","journal-title":"J Immunol"},{"key":"BFgt200993_CR52","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4049\/jimmunol.155.8.3734","volume":"155","author":"S Constant","year":"1995","unstructured":"Constant S, Schweitzer N, West J, Ranney P, Bottomly K . B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 1995; 155: 3734\u20133741.","journal-title":"J Immunol"},{"key":"BFgt200993_CR53","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.4049\/jimmunol.162.10.5695","volume":"162","author":"SL Constant","year":"1999","unstructured":"Constant SL . B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 1999; 162: 5695\u20135703.","journal-title":"J Immunol"},{"key":"BFgt200993_CR54","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.4049\/jimmunol.159.5.2282","volume":"159","author":"AI Jaiswal","year":"1997","unstructured":"Jaiswal AI, Croft M . CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. J Immunol 1997; 159: 2282\u20132291.","journal-title":"J Immunol"},{"key":"BFgt200993_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.coi.2005.03.003","volume":"17","author":"SL Peng","year":"2005","unstructured":"Peng SL . Signaling in B cells via toll-like receptors. Curr Opin Immunol 2005; 17: 230\u2013236.","journal-title":"Curr Opin Immunol"},{"key":"BFgt200993_CR56","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2002-11-3569","volume":"101","author":"NL Bernasconi","year":"2003","unstructured":"Bernasconi NL, Onai N, Lanzavecchia A . A role for toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003; 101: 4500\u20134504.","journal-title":"Blood"},{"key":"BFgt200993_CR57","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/eji.200636984","volume":"37","author":"W Jiang","year":"2007","unstructured":"Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF . TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 2007; 37: 2205\u20132213.","journal-title":"Eur J Immunol"},{"key":"BFgt200993_CR58","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.4049\/jimmunol.166.6.3717","volume":"166","author":"LA Harshyne","year":"2001","unstructured":"Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM . Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001; 166: 3717\u20133723.","journal-title":"J Immunol"},{"key":"BFgt200993_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2006.04.017","volume":"25","author":"RS Allan","year":"2006","unstructured":"Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25: 153\u2013162.","journal-title":"Immunity"},{"key":"BFgt200993_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","volume":"199","author":"WR Heath","year":"2004","unstructured":"Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004; 199: 9\u201326.","journal-title":"Immunol Rev"},{"key":"BFgt200993_CR61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","volume":"76","author":"TA Springer","year":"1994","unstructured":"Springer TA . Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301\u2013314.","journal-title":"Cell"},{"key":"BFgt200993_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/416094a","volume":"416","author":"K Reif","year":"2002","unstructured":"Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Forster R et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002; 416: 94\u201399.","journal-title":"Nature"},{"key":"BFgt200993_CR63","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.194.7.953","volume":"194","author":"W Weninger","year":"2001","unstructured":"Weninger W, Crowley MA, Manjunath N, von Andrian UH . Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med 2001; 194: 953\u2013966.","journal-title":"J Exp Med"},{"key":"BFgt200993_CR64","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1182\/blood-2004-01-0113","volume":"107","author":"M Bergwelt-Baildon","year":"2006","unstructured":"Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S et al. CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood 2006; 107: 2786\u20132789.","journal-title":"Blood"},{"key":"BFgt200993_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.immunol.21.090501.080131","volume":"22","author":"SD Rosen","year":"2004","unstructured":"Rosen SD . Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004; 22: 129\u2013156.","journal-title":"Annu Rev Immunol"},{"key":"BFgt200993_CR66","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.4049\/jimmunol.160.10.5113","volume":"160","author":"ML Tang","year":"1998","unstructured":"Tang ML, Steeber DA, Zhang XQ, Tedder TF . Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways. J Immunol 1998; 160: 5113\u20135121.","journal-title":"J Immunol"},{"key":"BFgt200993_CR67","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1182\/blood-2004-07-2556","volume":"105","author":"E Biagi","year":"2005","unstructured":"Biagi E, Dotti G, Yvon E, Lee E, Pule M, Vigouroux S et al. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes. Blood 2005; 105: 2436\u20132442.","journal-title":"Blood"},{"key":"BFgt200993_CR68","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.gt.3302008","volume":"10","author":"C Robert","year":"2003","unstructured":"Robert C, Klein C, Cheng G, Kogan A, Mulligan RC, von Andrian UH et al. Gene therapy to target dendritic cells from blood to lymph nodes. Gene Therapy 2003; 10: 1479\u20131486.","journal-title":"Gene Therapy"},{"key":"BFgt200993_CR69","volume-title":"Current Protocols in Immunology","author":"JE Coligan","year":"1991","unstructured":"Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W . Current Protocols in Immunology 1991\u20132008: John Wiley & Sons, Inc."},{"key":"BFgt200993_CR70","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.4049\/jimmunol.169.9.4778","volume":"169","author":"Z Hel","year":"2002","unstructured":"Hel Z, Nacsa J, Tryniszewska E, Tsai WP, Parks RW, Montefiori DC et al. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses. J Immunol 2002; 169: 4778\u20134787.","journal-title":"J Immunol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt200993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200993","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T05:32:27Z","timestamp":1685079147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt200993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,30]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFgt200993"],"URL":"https:\/\/doi.org\/10.1038\/gt.2009.93","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,30]]},"assertion":[{"value":"30 September 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}